$0.715000
00.00%
At close: -
Fresh Tracks Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fresh Tracks Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-30 | $-1.50 | $-1.43 | -4.90 % |
Sep 2022 | 2022-11-10 | $-2.07 | $-1.89 | -9.52 % |
Jun 2022 | 2022-08-11 | $-0.01 | $-2.05 | 99.5 % |
Mar 2022 | 2022-05-12 | $-3.60 | $-2.70 | -33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-30 | $2.05M | $2.50M | -18.0 % |
Sep 2022 | 2022-11-10 | $486.00K | $430.00K | 13.0 % |
Jun 2022 | 2022-08-11 | $4.32M | $3.13M | 37.9 % |
Mar 2022 | 2022-05-12 | $92.00K | $140.00K | -34.3 % |
Fresh Tracks Therapeutics (FRTX) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on March 15, 2024 for Q4.
The Actual EPS was $-0.20, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.